Amarin Corp Plcuk (AMRN) Current Deferred Tax Assets (2010 - 2016)

Amarin Corp Plcuk (AMRN) reported Current Deferred Tax Assets of $900000.0 for Q4 2016, up 200.0% year-over-year from $300000.0 in Q1 2016, and up 200.0% quarter-over-quarter from -$900000.0 in Q4 2015.

Amarin Corp Plcuk (AMRN) Current Deferred Tax Assets (2010 - 2016) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 7 years of Current Deferred Tax Assets data on file, last reported at $900000.0 in Q4 2016.

  • Current Deferred Tax Assets for Q4 2016 came in at $900000.0, up 200.0% year-over-year; the trailing twelve-month figure through Dec 2016 was $900000.0 (up 200.0% YoY), and the FY2016 annual result was $900000.0, up 200.0% from the prior year.
  • Current Deferred Tax Assets rose to $900000.0 in Q4 2016 per AMRN's latest filing, from -$900000.0 in the prior quarter.
  • Over five years, Current Deferred Tax Assets peaked at $937000.0 in Q4 2012 and troughed at -$900000.0 in Q4 2015.
  • A 5-year average of $645000.0 and a median of $900000.0 in 2016 frame the typical range for Current Deferred Tax Assets.
  • The sharpest annual moves came in 2015 and 2016: Current Deferred Tax Assets slumped 196.36% in 2015, then jumped 200.0% in 2016.
  • A 5-year view of Current Deferred Tax Assets shows it stood at $937000.0 in 2012, then sank by 49.73% to $471000.0 in 2013, then surged by 98.3% to $934000.0 in 2014, then tumbled by 196.36% to -$900000.0 in 2015, then jumped by 200.0% to $900000.0 in 2016.
  • Business Quant data shows AMRN's Current Deferred Tax Assets at $900000.0 in Q4 2016, -$900000.0 in Q4 2015, and $934000.0 in Q3 2015.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Amarin Corp Plcuk 6.77 Bn 6.59 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Dec 31, 2016 900,000.00
Dec 31, 2016 900,000.00
Dec 31, 2015 -900,000.00
Dec 31, 2015 -900,000.00
Sep 30, 2015 934,000.00
Sep 30, 2015 934,000.00
Jun 30, 2015 934,000.00
Jun 30, 2015 934,000.00
Mar 31, 2015 934,000.00
Mar 31, 2015 934,000.00
Dec 31, 2014 934,000.00
Dec 31, 2014 934,000.00
Sep 30, 2014 471,000.00
Sep 30, 2014 471,000.00
Jun 30, 2014 471,000.00
Jun 30, 2014 471,000.00
Mar 31, 2014 471,000.00
Mar 31, 2014 471,000.00
Dec 31, 2013 471,000.00
Dec 31, 2013 471,000.00